Stealth Biotech Startup Treeline Biosciences Raises $261M
crunchbase.com
tech
2022-10-17 18:29:29

Email Facebook Twitter LinkedIn An oncology company spearheaded by big names in biotech, but shrouded in ambiguity raised $261 million in new funding, according to STAT News.
The mysterious startup Treeline Biosciences was founded by oncology veteran Josh Bilenker, who previously worked in the oncology division of the Food and Drug Administration before founding another biotech company Loxo Oncology that sold for $8 billion to pharma giant Eli Lilley in 2019.Â 
 Grow your revenue with all-in-one prospecting solutions powered by the leader in private-company data.
